REDUCTION OF PORTAL VENOUS PRESSURE IN CIRRHOTIC PATIENTS WITH BLEEDING FROM OESOPHAGEAL VARICES, BY ADMINISTRATION OF A VASOPRESSIN DERIVATIVE, PHENYLALANINE-2-LYSINE-8-VASOPRESSIN.
D000293:Adolescent; D035843:Biomedical Research; D001794:Blood Pressure; D006328:Cardiac Catheterization; D004932:Esophageal and Gastric Varices; D006471:Gastrointestinal Hemorrhage; D005853:Geriatrics; D006801:Humans; D006973:Hypertension; D006975:Hypertension, Portal; D007263:Infusions, Parenteral; D008102:Liver Circulation; D008103:Liver Cirrhosis; D008239:Lysine; D010600:Pharmacology; D010649:Phenylalanine; D017082:Portal Pressure; D011169:Portal Vein; D014116:Toxicology; D014667:Vasopressins
D014667:Vasopressins; D010649:Phenylalanine; D008239:Lysine
ADOLESCENCE; BLOOD PRESSURE; CLINICAL RESEARCH; ESOPHAGEAL VARICES; GERIATRICS; HEART CATHETERIZATION; HEMORRHAGE, GASTROINTESTINAL; HYPERTENSION, PORTAL; INFUSIONS, PARENTERAL; LIVER CIRCULATION; LIVER CIRRHOSIS; LYSINE; PHARMACOLOGY; PHENYLALANINE; PORTAL VEIN; TOXICOLOGIC REPORT; VASOPRESSIN